Get Newsletter
Alzheimer Research Forum - Networking for a Cure Alzheimer Research Forum - Networking for a CureAlzheimer Research Forum - Networking for a Cure
  
What's New HomeContact UsHow to CiteGet NewsletterBecome a MemberLogin          
Papers of the Week
Current Papers
ARF Recommends
Milestone Papers
Search All Papers
Search Comments
News
Research News
Drug News
Conference News
Research
AD Hypotheses
  AlzSWAN
  Current Hypotheses
  Hypothesis Factory
Forums
  Live Discussions
  Virtual Conferences
  Interviews
Enabling Technologies
  Workshops
  Research Tools
Compendia
  AlzGene
  AlzRisk
  Antibodies
  Biomarkers
  Mutations
  Protocols
  Research Models
  Video Gallery
Resources
  Bulletin Boards
  Conference Calendar
  Grants
  Jobs
Early-Onset Familial AD
Overview
Diagnosis/Genetics
Research
News
Profiles
Clinics
Drug Development
Companies
Tutorial
Drugs in Clinical Trials
Disease Management
About Alzheimer's
  FAQs
Diagnosis
  Clinical Guidelines
  Tests
  Brain Banks
Treatment
  Drugs and Therapies
Caregiving
  Patient Care
  Support Directory
  AD Experiences
Community
Member Directory
Researcher Profiles
Institutes and Labs
About the Site
Mission
ARF Team
ARF Awards
Advisory Board
Sponsors
Partnerships
Fan Mail
Support Us
Return to Top
Home: News
News
News Search  
PKC Substrate Makes Its MARCKS on Dendritic Spines
9 October 2005. MARCKS, the myristoylated alanine-rich C kinase substrate, has been studied in non-neuronal cells for years as a regulator of cell shape and motility. A few researchers have noted alterations in MARCKS gene expression or protein phosphorylation in Alzheimer patients (Kimura et al., 2000) and suicide victims or people with bipolar disorder (McNamara et al., 1999; Pandey et al., 2003). The protein has been spotted in dendritic spines, but what it is doing there has been a mystery.

That has changed with a new report from Barbara Calabrese and Shelly Halpain from the Scripps Research Institute in La Jolla, California. In a paper published this week in Neuron, Calabrese and Halpain show that MARCKS functions in the maintenance and remodeling of dendritic spines in cultured hippocampal neurons. Their work also reveals that protein kinase C-catalyzed phosphorylation of MARCKS leads to dendritic spine remodeling, giving the protein a starring role in synaptic plasticity, learning and memory.

MARCKS knockout mice die around birth, so Calabrese and Halpain turned to cultured neurons to investigate the effects of MARCKS knockdown or overexpression. When the scientists expressed RNAi for MARCKS in 3-week-old cultures of rat hippocampal neurons, they observed a reduction in the density, width, and length of dendritic spines. But overexpression of MARCKS also caused a reduction in spine number, with increased length. From this, the authors concluded that MARCKS dynamically regulates spine stability and morphology, and this regulation is finely tuned.

MARCKS is a multitalented protein that binds to membranes (via a myristoyl moiety) and F-actin (via the effector domain), serving as a bridge between the cell surface and the actin cytoskeleton. When the effector domain gets phosphorylated by protein kinase C, MARCKS falls off the membrane, and its binding to actin is disrupted. To dissect the role of each domain, the researchers overexpressed mutant MARCKS proteins and carefully observed spine morphology and actin dynamics. Mutations in the effector domain that abolished PKC phosphorylation sites, or changed them to aspartic acid to mimic phosphorylation, both resulted in decreases in spine number, but in somewhat different ways. The unphosphorylatable mutant caused an increase in spine length, similar to that seen with overexpression of wild-type MARCKS. The opposite mutation, pseudophosphorylated MARCKS, induced a morphology similar to the knockdown, with reduced width and length. The different effects of the mutants reflected their different subcellular distributions: wild-type and nonphosphorylatable MARCKS were mostly membrane-associated, while the pseudophosphorylated protein was mainly cytosolic.

A look at the cytoskeletal rearrangements in these cells showed that the pseudophosphorylated MARCKS enhanced actin clustering in the spine head and reduced head motility. Decreased motility is often seen after glutamate receptor activation, raising the possibility that MARCKS phosphorylation by PKC could be responsible for real-life regulation of spine plasticity. Indeed, when the researchers treated neurons with the PKC activator phorbol ester, they recapitulated the loss of spines achieved with the pseudophosphorylated mutant, and this loss was prevented by expression of the nonphosphorylatable MARCKS.

It came as a bit of a surprise that loss of spines elicited by MARCKS mutant proteins was not associated with synapse loss. The same number of synapses seemed to be redistributed onto the remaining spines, and the synapses were functionally equivalent to those in normal cells as indicated by unchanged postsynaptic excitatory currents. These results show that even in the midst of MARCKS-influenced spine changes, synaptic function is maintained.

Dendritic spines put the plastic in synaptic plasticity—they proliferate during long-term potentiation and retrench during long-term depression. The identification of MARCKS as a player in this process jibes with another recent report implicating MARCKS in learning and memory in mouse hippocampus (McNamara et al., 2005), and should lead the way to more understanding of its involvement in AD and other neuropathologies.—Pat McCaffrey.

Reference:
Calabrese B, Halpain S. Essential Role for the PKC Target MARCKS in Maintaining Dendritic Spine Morphology. Neuron. 2005 Oct 6;48:77-90. Abstract

Matus A. MARCKS for Maintenance in Dendritic Spines. Neuron. 2005 Oct 6;48:4-5. Abstract

 
  Submit a Comment on this News Article
Cast your vote and/or make a comment on this news article. 

If you already are a member, please login.
Not sure if you are a member? Search our member database.

*First Name  
*Last Name  
Country or Territory:
*Login Email Address  
*Password    Minimum of 8 characters
*Confirm Password  
Stay signed in?  

I recommend the Primary Papers

Comment:

(If coauthors exist for this comment, please enter their names and email addresses at the end of the comment.)

References:


*Enter the verification code you see in the picture below:


This helps Alzforum prevent automated registrations.

Terms and Conditions of Use:Printable Version

By clicking on the 'I accept' below, you are agreeing to the Terms and Conditions of Use above.
Print this page
Email this page
Alzforum News
Papers of the Week
Text size
Share & Bookmark
ADNI Related Links
ADNI Data at LONI
ADNI Information
DIAN
Foundation for the NIH
AddNeuroMed
neuGRID
Desperately

Antibodies
Cell Lines
Collaborators
Papers
Research Participants
Copyright © 1996-2013 Alzheimer Research Forum Terms of Use How to Cite Privacy Policy Disclaimer Disclosure Copyright
wma logoadadad